Ginwa Enterprise (Group) Inc. (SHSE: 600080)
Health Care · Pharmaceuticals · CN
CN¥4.79
-1.64% today · -39.4% 1Y
Ginwa Enterprise (Group) Inc. (SHSE: 600080) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $251.32M and employs 613 people.
Over the last twelve months the share price has lost 39.4%, trading between 4.26 and 9.35.
Tweenvest scores Ginwa Enterprise (Group) Inc. across four factors: quality 74/100, value 51/100, growth 16/100, dividend 9/100. Its strongest factor is quality.
600080 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $251.32M
- Revenue (TTM)
- $80.73M
- P/E
- 167.63
- EPS
- 0.03
- Dividend yield
- 0.63%
- Beta (5Y)
- 0.06
- 52-week high
- CN¥9.35
- 52-week low
- CN¥4.26
- Avg volume (3M)
- —
- Shares outstanding
- 352.71M
- Employees
- 613
- Next earnings
- —
About Ginwa Enterprise (Group) Inc.
Ginwa Enterprise (Group) Inc. is a pharmaceutical company that specializes in the research, development, manufacturing, and commercialization of traditional Chinese, biological, and chemical medicines within China. The company's diverse product line encompasses treatments for a broad spectrum of medical conditions, including those related to orthopedics, immune system function, pediatric care, infectious diseases (such as antibiotics and antivirals), digestive health, gynecological issues, and cardiovascular ailments, as well as offerings for fever and pain relief. These medications are distributed in various common forms, specifically capsules, powders, and tablets. Ginwa Enterprise (Group) Inc. maintains its headquarters in Xi'an, China.
- ISIN
- CNE000000QQ8
- Founded
- 1996
- Listed since
- Jun 12, 1997
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.11T | $1,249.40 | +0.20% |
| Johnson & JohnsonNYSE: JNJ | $658.00B | $273.32 | +0.10% |
| Merck & Co., Inc.NYSE: MRK | $371.70B | $156.33 | +3.76% |
| Roche Holding AGSWX: ROP | $368.80B | CHF373.80 | +0.92% |
| Novartis AGSWX: NOVN | $300.52B | CHF126.76 | -0.52% |
| AstraZeneca PLCLSE: AZN | $256.25B | £124.76 | +3.02% |
| Novo Nordisk A/SCPSE: NOVO B | $206.64B | Dkr299.25 | -0.53% |
| Pfizer Inc.NYSE: PFE | $159.42B | $28.44 | +1.66% |
Figures last refreshed Aug 18, 2026.